Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Medicine Guides Lower, Blaming Economic Crisis

publication date: Oct 10, 2008

China Medicine Corporation said it will miss its 2009 revenue targets because of the global economic crisis. Previously, the company called for an increase of 25% to 35% in its top-line results. The company did not issue a revised forecast. However, China Medicine predicted that its 2009 net income would be better than expectations, which called for a rise of between 20% and 22%. China Medicine said the economic crisis was causing cash flow problems with customers, who are unable to get loans to fund operations. More details...

Stock Symbol: (OTCBB: CHME)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here